Better Therapeutics, Inc. (BTTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 38.26 Million USD | 25.2% |
| 2021 | 30.56 Million USD | 440.98% |
| 2020 | 5.64 Million USD | 15.45% |
| 2019 | 4.89 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q3 | 5.34 Million USD | -23.97% |
| 2023 Q1 | 8.92 Million USD | 7.25% |
| 2023 Q2 | 7.02 Million USD | -21.29% |
| 2022 Q3 | 10.99 Million USD | 14.55% |
| 2022 Q2 | 9.59 Million USD | 2.72% |
| 2022 Q1 | 9.34 Million USD | -22.79% |
| 2022 FY | 38.26 Million USD | 25.2% |
| 2022 Q4 | 8.32 Million USD | -24.32% |
| 2021 FY | 30.56 Million USD | 440.98% |
| 2021 Q4 | 12.1 Million USD | 4935.07% |
| 2021 Q3 | 240.39 Thousand USD | -96.2% |
| 2021 Q2 | 6.33 Million USD | 111.99% |
| 2021 Q1 | 2.98 Million USD | 136542.27% |
| 2020 Q1 | 1181.00 USD | 0.0% |
| 2020 FY | 5.64 Million USD | 15.45% |
| 2020 Q4 | 2186.00 USD | 14.33% |
| 2020 Q3 | 1912.00 USD | -99.78% |
| 2020 Q2 | 864 Thousand USD | 73058.34% |
| 2019 FY | 4.89 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| America Great Health | 661.23 Thousand USD | -5686.471% |
| Ampio Pharmaceuticals, Inc. | 9.26 Million USD | -312.84% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -27.57% |
| Biora Therapeutics, Inc. | 67.14 Million USD | 43.018% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -141.507% |
| Calithera Biosciences, Inc. | 40.68 Million USD | 5.965% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -208.746% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -13.054% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -11.165% |
| Evelo Biosciences, Inc. | 108.46 Million USD | 64.724% |
| Evolutionary Genomics, Inc. | 992.8 Thousand USD | -3753.913% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -17.408% |
| Galera Therapeutics, Inc. | 46.95 Million USD | 18.507% |
| Innovation1 Biotech Inc. | 1.21 Million USD | -3049.945% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -91.892% |
| Molecular Templates, Inc. | 63.09 Million USD | 39.354% |
| Navidea Biopharmaceuticals, Inc. | 13.93 Million USD | -174.642% |
| NexImmune, Inc. | 28.16 Million USD | -35.837% |
| Orgenesis Inc. | 45.75 Million USD | 16.38% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -49.187% |
| Point of Care Nano-Technology, Inc. | 73.41 Thousand USD | -52016.705% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -136.986% |
| Scopus BioPharma Inc. | 11.71 Million USD | -226.61% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | 90.519% |
| Statera Biopharma, Inc. | 28.82 Million USD | -32.718% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -102.134% |
| Trevena, Inc. | 38.41 Million USD | 0.393% |
| Vaxxinity, Inc. | 56.05 Million USD | 31.737% |
| Vaccinex, Inc. | 23.45 Million USD | -63.129% |
| Vicapsys Life Sciences, Inc. | 1.04 Million USD | -3554.518% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | 24.522% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -425.965% |